Close Menu

NEW YORK (GenomeWeb) – Non-profit fundraising organization Stand Up to Cancer (SU2C) announced today the launch of four research projects that will use genetic and other technologies to detect and treat cancer at its earliest stages.

The projects are part of the SU2C Cancer Interception initiative and will specifically focus on lung and pancreatic cancer. They will be be funded with a total of $16.6 million provided by SU2C, the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.